Healthy elderly Singaporeans show no age-related humoral hyporesponsiveness nor diminished plasmablast generation in response to influenza vaccine

Immun Ageing. 2018 Nov 12:15:28. doi: 10.1186/s12979-018-0137-4. eCollection 2018.

Abstract

Abstract: Improving influenza vaccine efficacy is a priority to reduce the burden of influenza-associated morbidity and mortality. By careful selection of individuals based on health we show sustained response to influenza vaccination in older adults. Sustaining health in aging could be an important player in maintaining immune responses to influenza vaccination.

Trial registration: NCT03266237. Registered 30 August 2017, https://clinicaltrials.gov/ct2/show/NCT03266237.

Keywords: Aging; Co-morbidity; Influenza vaccination; Stratification.

Associated data

  • ClinicalTrials.gov/NCT03266237